Over the past year, medical centers across the US have removed race adjustment from estimated glomerular filtration rate from serum creatinine (eGFRcr), with many now reporting the “White/other” value for all patients. These changes follow calls to reconsider the use of race in estimating kidney function1 and in medicine broadly.2 We analyzed potential changes in recommended care using eGFRcr with and without race among Black individuals in the US (individuals who are not Black would not be affected).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Diao JA, Wu GJ, Taylor HA, et al. Clinical Implications of Removing Race From Estimates of Kidney Function. JAMA. 2021;325(2):184–186. doi:10.1001/jama.2020.22124
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: